What is the treatment for asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Asthma treatment typically involves a combination of long-term control medications and quick-relief medications.

Long-term Control Medications

The most effective long-term control medications are those that attenuate the underlying inflammation characteristic of asthma, such as:

  • Inhaled Corticosteroids (ICSs), which are the most consistently effective long-term control medication at all steps of care for persistent asthma 1
  • Long-acting b2-agonists (LABAs), which are used in combination with ICSs for long-term control and prevention of symptoms in moderate or severe persistent asthma 1
  • Leukotriene modifiers, which can be used as alternative therapy for mild persistent asthma, but are not preferred compared to ICSs or LABAs 1
  • Immunomodulators, such as omalizumab, which can be used as adjunctive therapy for patients with severe persistent asthma 1

Quick-relief Medications

Quick-relief medications are used to treat acute symptoms and exacerbations, and include:

  • Short-acting b2-agonists (SABAs), such as albuterol, which are the treatment of choice for relief of acute symptoms and prevention of exercise-induced bronchospasm (EIB) 1
  • Anticholinergics, such as ipratropium bromide, which can be used as an alternative bronchodilator for patients who do not tolerate SABAs 1
  • Systemic corticosteroids, which are used for moderate and severe exacerbations to speed recovery and prevent recurrence of exacerbations 1

The goal of asthma treatment is to achieve and maintain control of persistent asthma, and the treatment approach should be stepped up or down based on the patient's response to treatment 1. It is also important to note that combination therapy, such as the addition of LABAs to ICSs, can be effective in achieving asthma control, especially in patients with moderate or severe persistent asthma 1.

From the Research

Treatment Options for Asthma

The treatment for asthma typically involves a combination of medications and lifestyle changes. The goal of treatment is to control symptoms, prevent exacerbations, and improve quality of life. Some of the treatment options for asthma include:

  • Inhaled corticosteroids, which are the most effective medications for long-term asthma control 2, 3
  • Short-acting beta2 agonists, which are preferred asthma reliever medications 3
  • Long-acting beta2 agonists, which can be used in combination with inhaled corticosteroids for controller and reliever treatments 3, 4
  • Leukotriene receptor antagonists, which can be used as add-on therapy for patients with mild to moderate asthma 2, 3
  • Anticholinergics, which can be used as add-on therapy for patients with severe asthma 2, 4

Stepwise Approach to Treatment

Asthma treatment typically follows a stepwise approach, with treatment intensity increasing as symptoms worsen 3, 4, 5, 6. This approach involves:

  • Assessing asthma severity and control at diagnosis and at subsequent visits
  • Initiating treatment with inhaled corticosteroids and adjusting as needed
  • Adding additional medications or increasing dosage in a stepwise fashion according to guideline-directed therapy recommendations
  • Considering single maintenance and reliever therapy for adults and adolescents with asthma 3

Emerging Therapies and Personalized Treatment

New biological therapies and developments in biomarkers present opportunities for phenotype-specific interventions and personalized treatment for severe asthma 5. Subcutaneous immunotherapy may be considered for patients with mild to moderate allergic asthma, while biologic agents may be considered for patients with severe allergic and eosinophilic asthma 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chronic Asthma Treatment: Common Questions and Answers.

American family physician, 2023

Research

Pharmacological treatment of asthma today.

The European respiratory journal. Supplement, 2001

Research

Asthma.

Lancet (London, England), 2018

Research

Treatment strategies for asthma: reshaping the concept of asthma management.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2020

Related Questions

What are the goals of care and treatment medications with doses for asthma management?
What is the recommended approach for asthma management?
What is the summary of asthma management?
What is the diagnosis and treatment approach for asthma?
What are the causes and protective measures for asthma?
How to differentiate Indolent infection, Spondyloarthritis (SpA), Crystal-induced arthritis, Still's disease (Juvenile Rheumatoid Arthritis (JRA)), and Early/Atypical polyarticular (polyarthritis) in Chronic Inflammatory Arthritis (CIA)?
What is the diagnosis for a 29-year-old female presenting with chronic fatigue, excessive daytime sleepiness, sleep paralysis, and a family history of narcolepsy, lupus, and rheumatoid arthritis, with symptoms including headaches, painful periods, seizures, loose stools, increasing Antinuclear Antibody (ANA) score, chronic pain, easy bruising, heat and cold intolerance, and hypermobile joints?
What is the diagnosis for a 29-year-old female presenting with chronic fatigue, excessive daytime sleepiness, sleep paralysis, and a family history of narcolepsy, lupus, and rheumatoid arthritis, with symptoms including headaches, painful periods, seizures, loose stools, increasing Antinuclear Antibody (ANA) score, chronic pain, easy bruising, heat and cold intolerance, and hypermobile joints?
How to differentiate between Lyme disease, indolent infection, and crystal-induced arthritis in chronic inflammatory arthritis?
What is the diagnosis for a 29-year-old female presenting with chronic fatigue, excessive daytime sleepiness, sleep paralysis, and a family history of narcolepsy, lupus, and rheumatoid arthritis, with symptoms including headaches, painful menstruation, seizures, loose stools, increasing Antinuclear Antibody (ANA) score, chronic pain, easy bruising, heat and cold intolerance, and hypermobile joints?
Why is the white blood cell count elevated while the neutrophil count is decreased in Acute Myeloid Leukemia (AML)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.